MedCity News

Green upward arrow pointing to a blue dollar sign on a pink background representing increasing profits, financial success, and economic growth

How Arintra’s Coding AI Helped Mercyhealth Boost Revenue by 5%

Grail’s Galleri Blood Test Falls Short in Large Cancer-Screening Study, Shares Sink 50%

Despite missing statistical significance, Grail said the observation of trending improvement suggests potential for better results with more time, so the company is extending follow up by up to a year. More detailed trial results will be submitted for presentation at the annual meeting of the American Society of Clinical Oncology.

By Frank Vinluan

Health Tech, Providers

Rainfall Health Raises $15M to Help Hospitals Navigate New CMS Model

Rainfall Health's Series A round was led by Two Bear Capital. In total, the startup has raised $18 million.

By Marissa Plescia

MedCity Influencers

Asian man using tablet in front of a blue screen of data

Proven Methodologies For Ensuring Seamless CRM Migrations In Highly Regulated Environments

Organizations that excel don’t treat migrations as IT exercises. They treat them as compliance projects that require technical execution. Their methodology begins with regulatory obligations, builds technical architecture around them, and conducts relentless validation before calling the migration complete.

By Roman Bevz

Latest Video

Latest News

MedCity Influencers

Shot of a doctor shaking hands with a patient in a wheelchair in a hospital corridor while his wife looks on

Weaving a Unified Fabric of Care Will Heal the Patient-Provider Relationship

Healthcare can transform only when strategy, workflow, data, and human connection operate together with a single purpose: strengthen the relationship at the center of care.

By Sachin K. Gupta

Health Tech

What Frist Cressey Ventures Will Target With Its $425M Healthcare Fund

Frist Cressey Ventures closed a $425 million fourth fund to invest in early-stage healthcare companies using AI to improve care, reduce costs and support the aging population.

By Marissa Plescia

Devices & Diagnostics, Health Tech, Providers

Several billion dollars. Conceptual image with american hundred dollar bills

Danaher Drops $10B to Snatch Masimo in Diagnostics Push

Danaher is acquiring Masimo in a $10 billion deal aimed at expanding its diagnostics portfolio and deepening its presence in acute care settings. The move reflects a broader industry shift toward consolidation and integrated care, as large healthcare companies seek scale and more continuous clinical data inside hospitals.

By Katie Adams

BioPharma, Startups

Novartis Commits $100M to Startup With Tech That Brings Peptides to Undruggable Targets

Novartis’s alliance with Unnatural Products is pursuing next-generation peptide drugs for cardiovascular disease. The startup already has drug R&D alliances with BridgeBio Pharma, Merck, and Argenx.

By Frank Vinluan

MedCity Influencers

Sustaining Clinician Independence: Why Simplicity, Not Consolidation, Is Key to Solving the Mental Health Crisis

Instead of adding more layers of complexity to an already strained system, there’s a more effective solution: make it simpler for independent clinicians to run a practice, participate in insurance networks directly, coordinate care, and provide treatment.

By Jonathan Seltzer

MedCity Influencers

Imaging Data Liquidity: The Foundation of Multimodal Medical Intelligence

Imaging has become a core input into how health systems understand disease, evaluate outcomes, plan capacity, and increasingly, how they learn.

By John Memarian

Artificial Intelligence, Hospitals, BioPharma

Anthropic: It’s “Critical” To Bring Company Products to EHR

The head of Anthropic's biology and life sciences business spoke about introducing "first-party" products, having a presence inside the EHR and what Claude can do for rural hospitals.

By Arundhati Parmar

The Power of One: Redefining Healthcare with an AI-Driven Unified Platform

In a landscape where complexity has long been the norm, the power of one lies not just in unification, but in intelligence and automation.

By David Cohen, Chief Product & Technology Officer, Greenway Health

Health Tech

Solera Health Launches Behavioral Health Network with Calm and Lyra

Solera Health has launched a behavioral health network that connects members to partners Calm Health and Lyra Health for digital mental health, coaching and therapy services.

By Marissa Plescia

BioPharma, Pharma

Eli Lilly Joins Chase for Hot Inflammation Target, Paying $100M for Rights to CSL Drug

CSL Limited retains rights to clazakizumab in end-stage kidney disease. Eli Lilly gets rights to the the IL-6-blocking antibody in other indications that could put it in competition with Novo Nordisk and Novartis.

By Frank Vinluan

MedCity Influencers

Healthcare’s AI Obsession Is Missing the Point on Nursing Shortages

Healthcare leaders must resist using AI as a substitute for staffing. Instead, invest in workforce optimization technology that empowers nurses, creates flexible pathways, and addresses the systemic issues driving burnout.

By Angie Nasr

MedCity Influencers

Addressing the 58% Launch Failure Rate: Accelerating Market Access Through Intelligent Decision-Making

Here are some of the structural and strategic causes behind that failure rate, and ways to improve launch outcomes.

By Lance Hill

Health Tech, Payers

Daffodil Health Secures $16.3M for Health Plan Administration Platform

Daffodil’s Series A round was led by Flare Capital Partners, with participation from LRVHealth and Maverick Ventures.

By Marissa Plescia

BioPharma, Pharma

Ocular Therapeutix Eyes FDA Filing After Wet AMD Drug Tops Regeneron’s Eylea in Phase 3 Test

In the first of two Phase 3 tests, Ocular Therapeutix’s Axpaxli met the main goal of helping maintain vision in patients with the wet form of age-related macular degeneration. The Ocular drug was compared to Eylea, a blockbuster wet AMD drug marketed by Regeneron Pharmaceuticals and Bayer.

By Frank Vinluan

MedCity Influencers

Regulatory Innovation as a Catalyst: How New Compliance Strategies Are Speeding Up Healthcare Technology Adoption

Regulatory frameworks are no longer simply gatekeepers of safety; they increasingly help ensure that new technologies are easier to understand, simpler to use, and more compatible with real-world healthcare settings.

By Parul Chansoria

MedCity Influencers

The Future of Pharmacy is Now – Health Systems Must Act to Drive Innovation, Access and Sustainability

By embracing innovation, optimizing operations and advocating for change, pharmacy leaders can ensure their organizations are not only prepared for the future but are actively shaping it.

By Matt Glucksmann